LGALS3 and COVID-19: Galectin-3 is a 29–35 kDa ß-galactoside binding lectin11 known to enhance the effects of viral infection by promoting host inflammatory responses12,13 and the release of several cytokines including IL-6 and TNF-α14, which are some of the major cytokines present in severe COVID-19 patients3.